Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type
1.3.2 Antibiotics
1.3.3 Antiviral
1.3.4 Antifungal
1.3.5 Amebicides
1.3.6 Anthelmintics
1.4 Market Segment by Application
1.4.1 Global Veterinary Infectious Diseases Therapeutics Market Share by Application (2019-2025)
1.4.2 Swine
1.4.3 Chicken
1.4.4 Dog
1.4.5 Cat
1.4.6 Cow
1.4.7 Horse
1.4.8 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Infectious Diseases Therapeutics Market Size
2.1.1 Global Veterinary Infectious Diseases Therapeutics Revenue 2014-2025
2.1.2 Global Veterinary Infectious Diseases Therapeutics Sales 2014-2025
2.2 Veterinary Infectious Diseases Therapeutics Growth Rate by Regions
2.2.1 Global Veterinary Infectious Diseases Therapeutics Sales by Regions 2014-2019
2.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
3.1.1 Veterinary Infectious Diseases Therapeutics Sales by Manufacturers 2014-2019
3.1.2 Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Veterinary Infectious Diseases Therapeutics Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Veterinary Infectious Diseases Therapeutics Market Concentration Ratio (CR5 and HHI)
3.3 Veterinary Infectious Diseases Therapeutics Price by Manufacturers
3.4 Key Manufacturers Veterinary Infectious Diseases Therapeutics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Veterinary Infectious Diseases Therapeutics Market
3.6 Key Manufacturers Veterinary Infectious Diseases Therapeutics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Antibiotics Sales and Revenue (2014-2019)
4.1.2 Antiviral Sales and Revenue (2014-2019)
4.1.3 Antifungal Sales and Revenue (2014-2019)
4.1.4 Amebicides Sales and Revenue (2014-2019)
4.1.5 Anthelmintics Sales and Revenue (2014-2019)
4.2 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type
4.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type
4.4 Veterinary Infectious Diseases Therapeutics Price by Type
5 Market Size by Application
5.1 Overview
5.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application
6 North America
6.1 North America Veterinary Infectious Diseases Therapeutics Breakdown Data by Company
6.2 North America Veterinary Infectious Diseases Therapeutics Breakdown Data by Type
6.3 North America Veterinary Infectious Diseases Therapeutics Breakdown Data by Application
6.4 North America Veterinary Infectious Diseases Therapeutics Breakdown Data by Countries
6.4.1 North America Veterinary Infectious Diseases Therapeutics Sales by Countries
6.4.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Veterinary Infectious Diseases Therapeutics Breakdown Data by Company
7.2 Europe Veterinary Infectious Diseases Therapeutics Breakdown Data by Type
7.3 Europe Veterinary Infectious Diseases Therapeutics Breakdown Data by Application
7.4 Europe Veterinary Infectious Diseases Therapeutics Breakdown Data by Countries
7.4.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Countries
7.4.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Breakdown Data by Company
8.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Breakdown Data by Type
8.3 Asia Pacific Veterinary Infectious Diseases Therapeutics Breakdown Data by Application
8.4 Asia Pacific Veterinary Infectious Diseases Therapeutics Breakdown Data by Regions
8.4.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Countries
8.4.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Veterinary Infectious Diseases Therapeutics Breakdown Data by Company
9.2 Central & South America Veterinary Infectious Diseases Therapeutics Breakdown Data by Type
9.3 Central & South America Veterinary Infectious Diseases Therapeutics Breakdown Data by Application
9.4 Central & South America Veterinary Infectious Diseases Therapeutics Breakdown Data by Countries
9.4.1 Central & South America Veterinary Infectious Diseases Therapeutics Sales by Countries
9.4.2 Central & South America Veterinary Infectious Diseases Therapeutics Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Breakdown Data by Type
10.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Breakdown Data by Application
10.3 Middle East and Africa Veterinary Infectious Diseases Therapeutics Breakdown Data by Countries
10.3.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Countries
10.3.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa
11 Company Profiles
11.1 Elanco Animal Health
11.1.1 Elanco Animal Health Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.1.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.1.5 Elanco Animal Health Recent Development
11.2 Novartis Animal Health
11.2.1 Novartis Animal Health Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.2.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.2.5 Novartis Animal Health Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.3.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.3.5 Merck Recent Development
11.4 Pfizer Animal Health
11.4.1 Pfizer Animal Health Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.4.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.4.5 Pfizer Animal Health Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.5.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.5.5 Sanofi Recent Development
11.6 Boehringer Ingelheim Vetmedica
11.6.1 Boehringer Ingelheim Vetmedica Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.6.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.6.5 Boehringer Ingelheim Vetmedica Recent Development
11.7 Dechra Animal Health
11.7.1 Dechra Animal Health Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.7.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.7.5 Dechra Animal Health Recent Development
11.8 Ceva Sante Animale
11.8.1 Ceva Sante Animale Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.8.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.8.5 Ceva Sante Animale Recent Development
11.9 Elanco Animal Health
11.9.1 Elanco Animal Health Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.9.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.9.5 Elanco Animal Health Recent Development
11.10 Virbac
11.10.1 Virbac Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.10.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.10.5 Virbac Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Veterinary Infectious Diseases Therapeutics Sales Channels
12.2.2 Veterinary Infectious Diseases Therapeutics Distributors
12.3 Veterinary Infectious Diseases Therapeutics Customers
13 Market Forecast
13.1 Global Veterinary Infectious Diseases Therapeutics Sales and Revenue Forecast 2019-2025
13.2 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Type
13.3 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Application
13.4 Veterinary Infectious Diseases Therapeutics Forecast by Regions
13.4.1 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Regions 2019-2025
13.4.2 Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Veterinary Infectious Diseases Therapeutics Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Veterinary Infectious Diseases Therapeutics Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Veterinary Infectious Diseases Therapeutics Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Elanco Animal Health、Novartis Animal Health、Merck、Pfizer Animal Health、Sanofi、Boehringer Ingelheim Vetmedica、Dechra Animal Health、Ceva Sante Animale、Elanco Animal Health、Virbac